Smart Education for MACE Prevention and Early Detection
SEED
Smart Education for Major Adverse Cardiovascular Events Prevention and Early Detection
1 other identifier
interventional
87,376
0 countries
N/A
Brief Summary
With its high incidence, recurrence, disability, and mortality, stroke has become a significant health challenge in society today. However, "stroke can be prevented and treated," and high-risk groups for stroke are the primary beneficiaries of stroke prevention and control measures. Yet, these populations often have low awareness of proper stroke prevention and treatment knowledge. The reasons for this may include limited coverage, lack of accessibility, inadequate relevance, and uneven content quality in traditional health education measures. To address these issues, innovative intervention strategies are needed to explore more effective health education methods. The occurrence of Major Adverse Cardiovascular Events (MACE), such as stroke, can be reduced by improving the knowledge and practical abilities of high-risk populations regarding scientific stroke prevention and treatment. One such strategy is the use of smartphone-based information software, which can break the constraints of time and space, delivering health education knowledge to a broader audience. To enhance accessibility, key knowledge points can be repeatedly delivered to the target population through one-way push notifications and interactive Q\&A, allowing for more engaging and flexible learning. In terms of improving pertinence, it is essential to tailor health education delivery to the individual needs of the educatees, considering factors such as age, education level, and risk factors. Furthermore, the quality of health education content must be authoritative, scientifically accurate, easy to understand, and practically applicable. The content should be based on the latest scientific research and professional medical practice, reviewed by authoritative institutions or experts, and should align with the needs of the educated populations for self-health management. Additionally, human and financial costs should be considered when designing such interventions. In this study, a large-scale medical model based on a stroke prevention and treatment knowledge base, integrated with an intelligent medical system and interactive Q\&A, is employed. This approach ensures content quality while minimizing the need for additional manpower in education and Q\&A, making the intervention more cost-effective and scalable for widespread use. The purpose of this study is to explore whether the incidence of MACE in a high-risk stroke population receiving interactive medical model education-based on a stroke prevention and treatment knowledge base-is lower than in a group without such interactive education.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2025
CompletedFirst Posted
Study publicly available on registry
February 10, 2025
CompletedStudy Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2027
ExpectedFebruary 10, 2025
January 1, 2025
12 months
February 4, 2025
February 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MACE Incidence
The occurrence of major adverse cardiovascular events (MACE), including stroke (ischemic or hemorrhagic), myocardial infarction, heart failure, or cardiovascular death, in participants over the 1-year follow-up period. MACE is a composite outcome that captures the broad range of adverse cardiovascular events.
1 year from enrollment
Secondary Outcomes (10)
Stroke Incidence
1 year from enrollment
Hospitalization Due to Cardiovascular Events
1 year from enrollment
Stroke Prevention and Treatment Knowledge
1 year from enrollment
Blood Pressure Control
1 year from enrollment
Physical Function and Quality of Life (QoL)
1 year from enrollment
- +5 more secondary outcomes
Study Arms (2)
Intervention Group
EXPERIMENTALHigh-risk stroke population receiving interactive education based on a medical knowledge model, utilizing intelligent medical agents and interactive Q\&A. The educational content will cover stroke prevention and treatment, tailored to individual risk factors and needs.
Control Group
ACTIVE COMPARATORHigh-risk stroke population receiving traditional health education methods without the use of the interactive medical model and intelligent Q\&A system.
Interventions
interactive education based on a medical knowledge model, utilizing intelligent medical agents and interactive Q\&A
traditional health education methods without the use of the interactive medical model and intelligent Q\&A system
Eligibility Criteria
You may qualify if:
- Individuals who meet the definition of a stroke risk group, including those with hypertension, dyslipidemia, diabetes, atrial fibrillation, valvular heart disease, a history of smoking, significant overweight or obesity, physical inactivity, a family history of stroke, or any combination of 8 or more stroke risk factors.
- Individuals with a history of one or more transient ischemic attacks (TIAs) or a previous stroke.
- Legal capacity to provide informed consent. Permanent residents of Zhejiang Province with Zhejiang Provincial household registration.
- Ownership of a smartphone and access to the Alipay app. Voluntary participation and adherence to the principles of informed consent.
You may not qualify if:
- Illiteracy or difficulty with reading/communication. Medical personnel. Inability to complete the study questionnaire due to physical or cognitive limitations.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2025
First Posted
February 10, 2025
Study Start
March 1, 2025
Primary Completion
February 28, 2026
Study Completion (Estimated)
February 28, 2027
Last Updated
February 10, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share